These results confirmed that B7-H4 is a regulatory molecule engaged in negative signaling that impacts anti-responses mediated by T cells in ccRCC, and also establishes a new paradigm for ccRCC cell eradication using B7-H4-based targeting. The gene discussed is VTCN1; the disease is nonpapillary renal cell carcinoma.